Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998206203> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2998206203 endingPage "4834" @default.
- W2998206203 startingPage "4828" @default.
- W2998206203 abstract "MiR-564 has been discovered to be abnormally expressed in human malignancy. Two recent studies suggested that miR-564 plays a role in tumor inhibition in both lung and breast cancer. However, no evidence reported the mechanism and function of miR-564 in prostate cancer (PCa).The PCa tissues and their adjacent normal tissues were collected from 50 PCa patients. Expressions of miR-564 in tissues and cells were evaluated with RT-qPCR. The MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide] assay, flow cytometry and Western-blot analysis, were applied to detect the proliferation, cell cycle progression and the protein expression of PCa cell lines (PC-3 and DU-145). Migration and invasion of PCa cells were analyzed by Transwell assays. Furthermore, the correlation between miR-564 and MLLT3 was assessed by luciferase reporter assay. Also, the PCa cells were transfected with miR-564 mimics control and inhibitor.In our present research, miR-564 was found dysregulated in PCa cells and to act as a suppressor in PCa cell proliferation, progression of cell cycle, cell invasion and migration. MLLT3 (also known as Af9) is a proto-oncogene, which has first reported in leukemia, and the regulation of its expression remains incompletely elucidated. Also, it is first reported in our study, suggesting that MLLT3 is a direct target of miR-564. The results also showed a significant negative correlation with miR-564 in PCa cells. Furthermore, up-regulation of MLLT3 attenuates the effects of miR-564 on the ability of PCa cells.Our research demonstrated the suppressor function of miR-564 in PCa, revealing restoration of miR-564 as a potential therapeutic strategy for the treatment of PCa." @default.
- W2998206203 created "2020-01-10" @default.
- W2998206203 creator A5044847414 @default.
- W2998206203 creator A5051764626 @default.
- W2998206203 creator A5060382946 @default.
- W2998206203 creator A5080294691 @default.
- W2998206203 date "2017-11-01" @default.
- W2998206203 modified "2023-09-23" @default.
- W2998206203 title "miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3." @default.
- W2998206203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29164580" @default.
- W2998206203 hasPublicationYear "2017" @default.
- W2998206203 type Work @default.
- W2998206203 sameAs 2998206203 @default.
- W2998206203 citedByCount "7" @default.
- W2998206203 countsByYear W29982062032019 @default.
- W2998206203 countsByYear W29982062032021 @default.
- W2998206203 countsByYear W29982062032022 @default.
- W2998206203 crossrefType "journal-article" @default.
- W2998206203 hasAuthorship W2998206203A5044847414 @default.
- W2998206203 hasAuthorship W2998206203A5051764626 @default.
- W2998206203 hasAuthorship W2998206203A5060382946 @default.
- W2998206203 hasAuthorship W2998206203A5080294691 @default.
- W2998206203 hasConcept C121608353 @default.
- W2998206203 hasConcept C126322002 @default.
- W2998206203 hasConcept C142724271 @default.
- W2998206203 hasConcept C203014093 @default.
- W2998206203 hasConcept C2779013556 @default.
- W2998206203 hasConcept C2780192828 @default.
- W2998206203 hasConcept C2781018059 @default.
- W2998206203 hasConcept C29537977 @default.
- W2998206203 hasConcept C502942594 @default.
- W2998206203 hasConcept C54009773 @default.
- W2998206203 hasConcept C54355233 @default.
- W2998206203 hasConcept C553184892 @default.
- W2998206203 hasConcept C62112901 @default.
- W2998206203 hasConcept C71924100 @default.
- W2998206203 hasConcept C81885089 @default.
- W2998206203 hasConcept C86803240 @default.
- W2998206203 hasConceptScore W2998206203C121608353 @default.
- W2998206203 hasConceptScore W2998206203C126322002 @default.
- W2998206203 hasConceptScore W2998206203C142724271 @default.
- W2998206203 hasConceptScore W2998206203C203014093 @default.
- W2998206203 hasConceptScore W2998206203C2779013556 @default.
- W2998206203 hasConceptScore W2998206203C2780192828 @default.
- W2998206203 hasConceptScore W2998206203C2781018059 @default.
- W2998206203 hasConceptScore W2998206203C29537977 @default.
- W2998206203 hasConceptScore W2998206203C502942594 @default.
- W2998206203 hasConceptScore W2998206203C54009773 @default.
- W2998206203 hasConceptScore W2998206203C54355233 @default.
- W2998206203 hasConceptScore W2998206203C553184892 @default.
- W2998206203 hasConceptScore W2998206203C62112901 @default.
- W2998206203 hasConceptScore W2998206203C71924100 @default.
- W2998206203 hasConceptScore W2998206203C81885089 @default.
- W2998206203 hasConceptScore W2998206203C86803240 @default.
- W2998206203 hasIssue "21" @default.
- W2998206203 hasLocation W29982062031 @default.
- W2998206203 hasOpenAccess W2998206203 @default.
- W2998206203 hasPrimaryLocation W29982062031 @default.
- W2998206203 hasRelatedWork W2349188094 @default.
- W2998206203 hasRelatedWork W2361868181 @default.
- W2998206203 hasRelatedWork W2363484836 @default.
- W2998206203 hasRelatedWork W2381476352 @default.
- W2998206203 hasRelatedWork W2384468042 @default.
- W2998206203 hasRelatedWork W2391801833 @default.
- W2998206203 hasRelatedWork W2392234861 @default.
- W2998206203 hasRelatedWork W2411390991 @default.
- W2998206203 hasRelatedWork W2425089811 @default.
- W2998206203 hasRelatedWork W3029576310 @default.
- W2998206203 hasVolume "21" @default.
- W2998206203 isParatext "false" @default.
- W2998206203 isRetracted "false" @default.
- W2998206203 magId "2998206203" @default.
- W2998206203 workType "article" @default.